Active Overwrite Commentary

2024 Active Overwrite Commentary – Q3

Read our Q3 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2024 Q3 Active Overwrite Commentary
Read More →

2024 Active Overwrite Commentary – Q2

Read our Q2 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2024 Q2 Active Overwrite Commentary
Read More →

2024 Active Overwrite Commentary – Q1

Read our Q1 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2024 Q1 Active Overwrite Commentary
Read More →

2023 Active Overwrite Commentary – Q4

Read our Q4 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2023 Q4 Active Overwrite Commentary
Read More →

Active Overwrite Performance Summary – Q3 2023

The Gateway Active Index-Option Overwrite Composite (the Composite) provided strong equity market participation and downside loss mitigation as it continued to benefit from an environment ...
Read More →

2023 Active Overwrite Commentary – Q3

Read our Q3 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2023 Q3 Active Overwrite Commentary
Read More →

Active Overwrite Performance Summary – Q2 2023

Since the start of the year, the Gateway Active Index-Option Overwrite Composite (the Composite) climbed 13.57%, net of fees, compared to the 10.47% and 16.89% ...
Read More →

2023 Active Overwrite Commentary – Q2

Read our Q2 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2023 Q2 Active Overwrite Commentary
Read More →

2023 Active Overwrite Commentary – Q1

Read our Q1 Active Overwrite Commentary for a review of strategy performance and positioning during the quarter.  2023 Q1 Active Overwrite Commentary
Read More →

Active Overwrite Performance Summary – Q1 2023

Most of the Composite’s outperformance relative to the BXMSM occurred during March, as its active approach led to consistent market exposure and risk profile throughout ...
Read More →